Antara Capital LP — 13F Holdings & Portfolio
CIK 1750183 · latest 13F-HR filed 2026-02-17
Antara Capital LP manages $30.2K in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2025-12-31 13F-HR filing. Its largest disclosed positions are ASBPW (88.65%), ASBPW (11.35%). Quarter over quarter (versus its 2025-09-30 filing) the fund opened 0 new positions and exited 1; 0 existing positions rose in reported value and 2 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-02-17
vs 2025-09-30
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q4 25Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q3 25 → Q4 25Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
2 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 100%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 31, 2026.
NEW YORK, NY 10004
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| GULATI, HIMANSHU Control | CHIEF INVESTMENT OFFICER AND MANAGING PARTNER since Mar 2018 | 75% or more | Individual |
| ANTARA CAPITAL GP LLC | GENERAL PARTNER since Mar 2018 | Less than 5% | Domestic Entity |
| HECKERLING, JEREMY, A | CHIEF COMPLIANCE OFFICER since Aug 2025 | Less than 5% | Individual |
| GULATI, HIMANSHU Control Indirect owner via ANTARA CAPITAL GP LLC | OWNER/GENERAL PARTNER since Mar 2018 | 75% or more | Individual |
Ownership & leadership changes · 3 filings with changes since Aug 1, 2018
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedPOSNER, RAPH, ASHER · CHIEF COMPLIANCE OFFICER, GENERAL COUNSEL · Less than 5% · control person · listed since Feb 2021
- AddedHECKERLING, JEREMY, A · CHIEF COMPLIANCE OFFICER · Less than 5%
- No longer listedKRAVITZ, LANCE, ADAM · CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER · Less than 5% · control person · listed since Mar 2018
- AddedPOSNER, RAPH, ASHER · CHIEF COMPLIANCE OFFICER, GENERAL COUNSEL · Less than 5% · control person
- ChangedKRAVITZ, LANCE, ADAM · title CHIEF OPERATING OFFICER/CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER
- ListedANTARA CAPITAL GP LLC · GENERAL PARTNER · Less than 5%
- ListedGULATI, HIMANSHU · CHIEF INVESTMENT OFFICER AND MANAGING PARTNER · 75% or more · control person
- ListedGULATI, HIMANSHU · OWNER/GENERAL PARTNER · 75% or more · indirect via ANTARA CAPITAL GP LLC · control person
- ListedKRAVITZ, LANCE, ADAM · CHIEF OPERATING OFFICER/CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Trims
- ASPIRE BIOPHARMA HLDGS INC-$15.0K -36.0%
- ASPIRE BIOPHARMA HLDGS INC-$2.8K -44.8%
Antara Capital LP Holdings (2025-12-31)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2025-12-31 | 2026-02-17 | $30.2K | 2 | 0001172661-26-001155 |
| 2025-09-30 | 2025-11-14 | $490.2K | 3 | 0001750183-25-000016 |